Effects of Solarplast Supplement on Recovery After Heavy Exercise
Effects of Solarplast (R) Supplementation on Biomarkers of Muscle Damage, Inflammation and Recovery of Physical Performance Following High-intensity Resistance Exercise
This study tests whether taking a Solarplast supplement can help active adults recover better from muscle soreness and inflammation after intense workouts.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Sponsor | Kent State University Academic / other |
| Locations | 1 site (Kent, Ohio) |
| Trial ID | NCT06432868 on ClinicalTrials.gov |
What this trial studies
This investigation aims to evaluate the impact of Solarplast (R) supplementation on recovery from muscle damage and inflammation following high-intensity resistance exercise in active adults. Participants will take either Solarplast (R) or a placebo daily for four weeks and will undergo heavy resistance training sessions with follow-up testing. The study will assess whether Solarplast (R) can mitigate performance decline and enhance recovery compared to a placebo. Regular laboratory visits will be required for supplement administration and performance assessments.
Who should consider this trial
Good fit: Ideal candidates are recreationally active adults who engage in regular weight training and meet specific health criteria.
Not a fit: Patients who are not regularly active or have physical limitations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance recovery strategies for individuals engaging in high-intensity resistance training.
How similar studies have performed: While there is ongoing research into recovery supplements, the specific effects of Solarplast (R) in this context are novel and not extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Recreationally-active (participated in at least 2 weight training workouts per week over the previous year) and participates in at least 3h of total structured exercise/week as determined by the health and activity questionnaire. * Subject is judged by the Investigator to be healthy and free of any physical limitations (determined by health and activity questionnaire) * Subject has a body mass index of 18.0-34.9 kg/m2, inclusive * Subject is willing to maintain habitual diet throughout the study period * Subject is willing to abstain from dietary supplementation throughout the duration of the study. * Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators Exclusion Criteria: * Subject is currently or will be enrolled in another clinical trial. * Subject is a habitual consumer of tea/antioxidants defined as \> 8 oz/day of either green or black tea within the 14 days prior to the screening visit. * Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder. * Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer. * Subject is unable to perform physical exercise (determined by health and activity questionnaire) * Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc. * Subject is allergic to the study product or placebo * Subject is taking any other nutritional supplement or performance enhancing drug (determined from health and activity questionnaire) * Subject has any chronic illness that causes continuous medical care * Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.
Where this trial is running
Kent, Ohio
- Kent State University - Exercise Science & Exercise Physiology — Kent, Ohio, United States (Recruiting)
Study contacts
- Study coordinator: Adam R Jajtner, PhD
- Email: ajajtner@kent.edu
- Phone: 330-672-0212
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.